Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER NZAus Randomized Placebo-Controlled Trial

Sarah L. Harris, Chris McKinlay, Katie Groom, Friederike Beker, Anuradha Kochar, Andrew Gill

Research output: Contribution to journalArticlepeer-review

Abstract

We evaluated the effect of antenatal sildenafil on neonatal cardiovascular function in a subgroup of 27 infants of mothers participating in the STRIDER-NZAus randomized controlled trial. In this small study, we found no association between antenatal sildenafil and neonatal cardiac dysfunction including no pulmonary hypertension in exposed or unexposed infants.

Original languageEnglish
Article number100009
JournalThe Journal of Pediatrics: X
Volume1
DOIs
Publication statusPublished - 1 Mar 2019

Fingerprint

Dive into the research topics of 'Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER NZAus Randomized Placebo-Controlled Trial'. Together they form a unique fingerprint.

Cite this